Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. scores highest on Torque (85) and lowest on Price (48). Its PosiPenta is 58.39 out of 100, around the middle of similar companies.
On the Penta Grid this week, Santen Pharmaceutical Co., Ltd. is Grid #16 of 47 in the Healthcare sector in Japan, and Grid #217 of 871 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 58.39 | 48 | 50 | 57 | 85 | 52 |
| Kusuri No Aoki Holdings Co., Ltd. | 58.52 | 23 | 64 | 85 | 47 | 73 |
| Sumitomo Pharma Co., Ltd. | 47.41 | 62 | 32 | 22 | 76 | 44 |
| Tsuruha Holdings Inc. | 55.54 | 59 | 72 | 35 | 48 | 64 |
| Tsumura & Co. | 61.45 | 82 | 69 | 48 | 48 | 60 |
| M3, Inc. | 39.22 | 15 | 38 | 35 | 67 | 41 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 14.67 |
| P/B ratio | 1.89 |
EEarnings
| Trailing EPS | ₹72.74 |
| Forward EPS | ₹65.41 |
NNitro
| Price | 1067.26 |
| 52-week high | 1364.49 |
| 52-week low | 882.62 |
| Fall from 52-week high | 21.8% |
TTorque
| Return on equity (ROE) | 13.43% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹34,289 Cr |
| Insider holding | 2.93% |
| Dividend yield | 2.40% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Santen Pharmaceutical Co., Ltd.'s PosiPenta score?
Santen Pharmaceutical Co., Ltd.'s PosiPenta is 58.39 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Santen Pharmaceutical Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, Santen Pharmaceutical Co., Ltd. is Grid #16 of 47 in the Healthcare sector in Japan, and Grid #217 of 871 in Japan.
Which PosiPenta pillar is strongest for Santen Pharmaceutical Co., Ltd.?
Torque (durability), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Santen Pharmaceutical Co., Ltd.?
Price (valuation), with a score of 48 out of 100: around the middle of similar companies.
PositoAI is for research and education only and is not investment advice.